Coping with chronic social stress in mice: Hypothalamic-pituitary-adrenal/ sympathetic-adrenal-medullary axis activity, behavioral changes and effects of antalarmin treatment: Implications for the study of stress-related psychopathologies

Neuroendocrinology

Volumn 98, Issue 1, 2013, Pages 73-88

  Pérez Tejada, Joana ^a   Arregi, Amaia ^a   Gómez Lázaro, Eneritz ^a   Vegas, Oscar ^a   Azpiroz, Arantza ^a   Garmendia, Larraitz ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Antalarmin; Catecholamine; Catecholamine enzyme synthesis; Chronic social stress; Coping; Corticosterone; Corticotrophin releasing hormone; Mice; Mood disorders

Indexed keywords

ADRENALIN; ANTALARMIN; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE BETA MONOOXYGENASE; MESSENGER RNA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ADRENALIN BLOOD LEVEL; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CHRONIC STRESS; CONTROLLED STUDY; COPING BEHAVIOR; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; ENDOCRINE FUNCTION; EXPERIMENTAL MOUSE; FORCED SWIMMING TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NUCLEOTIDE SEQUENCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REST; SENSORY STIMULATION; SOCIAL STRESS; STIMULUS RESPONSE; SYMPATHETIC ADRENAL MEDULLARY AXIS; ADULT; DRUG MECHANISM; EXPERIMENTAL ANIMAL; FORCED SWIM TEST; PHENOTYPE; PROTEIN EXPRESSION;

ADAPTATION, PSYCHOLOGICAL; ADRENAL MEDULLA; ANIMALS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERPERSONAL RELATIONS; MALE; MICE; PITUITARY-ADRENAL SYSTEM; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PSYCHOLOGICAL;

EID: 84881542290     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000353620     Document Type: Article

References (70)

1. Cryan JF, Slattery DA: Animal models of mood disorders: recent developments. Curr Opin Psychiatry 2007; 20:1-7.
2. Walker FR, Masters LM, Dielenberg RA, Day TA: Coping with defeat: acute glucocorticoid and forebrain responses to social defeat vary with defeat episode behavior. Neuroscience 2009; 162:244-253.
3. Koolhaas JM, Korte SM, De Boer SF, Van Der Vegt BJ, Van Reenen CG, Hopster H, De Jong IC, Ruis MAW, Blokhuis HJ: Coping styles in animals: current status in behavior and stress-physiology. Neurosci Biobehav Rev 1999; 23: 925-935.
4. Veenema AH, Meijer OC, de Kloet ER, Koolhaas JM, Bohus BG: Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Horm Behav 2003; 43:197-204.
5. Gomez-Lazaro E, Garmendia L, Beitia G, Per-ez-Tejada J, Azpiroz A, Arregi A: Effects of a putative antidepressant with a rapid onset of action in defeated mice with different coping strategies. Prog Neuropsychopharmacol Biol Psychiatry 2012; 38:317-327.
6. De Miguel Z, Vegas O, Garmendia L, Arregi A, Beitia G, Azpiroz A: Behavioral coping strategies in response to social stress are associated with distinct neuroendocrine, mono-aminergic and immune response profiles in mice. Behav Brain Res 2011; 225:554-561.
7. Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstätter M, Zeh R, Zimbelmann M, Holsboer F, Landgraf R: Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psy-choneuroendocrinology 2008; 33:839-862.
8. Gold PW, Chrousos GP: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatr 2002; 7:254-275.
9. de Kloet ER, Joels M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6:463-475.
10. Nemeroff CB, Bremner JD, Foa EB, Mayberg HS, North CS, Stein MB: Posttraumatic stress disorder: a state-of-the-science review. J Psy-chiatr Res 2006; 40:1-21.
11. Kehne JH: The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol Disord Drug Targets 2007; 6:163-182.
12. Kasckow JW, Baker D, Geracioti TD: Cortico-tropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 2001; 22:845-851.
13. Yehuda R, Southwick SM, Nussbaum G, Wahby V, Giller EL, Mason JW: Low urinary cortisol excretion in patients with posttrau-matic stress disorder. J Nerv Ment Dis 1990; 178:366-369.
14. Miczek KA: New test for aggression in rats without aversive stimulation: differential effects of d-amphetamine and cocaine. Psycho-pharmacology (Berl) 1979; 60:253-259.
15. Zoladz PR, Fleshner M, Diamond DM: Psy-chosocial animal model of PTSD produces a long-lasting traumatic memory, an increase in general anxiety and PTSD-like glucocorti-coid abnormalities. Psychoneuroendocrinol-ogy 2012; 37:1531-1545.
16. Müller MB, Holsboer F: Mice with mutations in the HPA-system as models for symptoms of depression. Biol Psychiatry 2006; 59:1104-1115.
17. Koolhaas J, Bohus B: Animal models of stress and immunity; in Leonard B, Miller K (eds): Stress, the Immune System and Psychiatry. New York, Wiley and Sons, 1995.
18. Kudryavtseva NN, Bakshtanovskaya IV, Ko-ryakina LA: Social model of depression in mice of C57BL/6J strain. Pharmacol Biochem Behav 1991; 38:315-320.
19. Gomez-Lazaro E, Arregi A, Beitia G, Vegas O, Azpiroz A, Garmendia L: Individual differences in chronically defeated male mice: behavioral, endocrine, immune, and neuro-trophic changes as markers of vulnerability to the effects of stress. Stress 2011; 14: 537-548.
20. Hellhammer DH, Wade S: Endocrine correlates of stress vulnerability. Psychother Psy-chosom 1993; 60:8-17.
21. Fries E, Hesse J, Hellhammer J, Hellhammer DH: A new view on hypocortisolism. Psycho-neuroendocrinology 2005; 30:1010-1016.
22. Uschold-Schmidt N, Nyuyki KD, Füchsl AM, Neumann ID, Reber SO: Chronic psychoso-cial stress results in sensitization of the HPA axis to acute heterotypic stressors despite a reduction of adrenal in vitro ACTH responsiveness. Psychoneuroendocrinology 2012; 10: 1676-1687.
23. Flandreau EI, Ressler KJ, Owens MJ, Nemeroff CB: Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventric-ular nucleus of the hypothalamus. Psychoneu-roendocrinology 2012; 37:27-38.
24. Sgoifo A, De Boer SF, Haller J, Koolhaas JM: Individual differences in plasma catechol-amine and corticosterone stress responses of wild-type rats: relationship with aggression. Physiol Behav 1996; 60:1403-1407.
25. Agelink MW, Boz C, Ullrich H, Andrich J: Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002; 113:139-149.
26. Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S, Koeppe RA, Fig LM: Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 1999; 45:817-826.
27. Grigoriadis DE: The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders. Expert Opin Ther Targets 2005; 9:651-684.
28. Gutman DA, Owens MJ, Thrivikraman KV, Nemeroff CB: Persistent anxiolytic affects after chronic administration of the CRF1 receptor antagonist R121919 in rats. Neurophar-macology 2011; 60:1135-1141.
29. Golde WT, Gollobin P, Rodriguez LL: A rapid, simple, and humane method for subman-dibular bleeding of mice using a lancet. Lab Anim (NY) 2005; 34:39-43.
30. Paxinos G, Franklin KBJ: The Mouse Brain in Stereotaxic Coordinates. San Diego, Academic Press, 2001.
31. Kudryatseva NN: Sensory contact model: protocol, control, applications. Nature Pre-cedings 2009. http://hdl.handle.net/10101/npre.2009.3299.1.
32. Brain PF, McAllister KH, Walmsley S: Drug effects on social behavior: methods in etho-pharmacology; in Boulton AA, Baker GB, Greenshaw AJ (eds): Neuromethods. Totowa, Humana Press, 1989, pp 687-739.
33. Merali Z, Levac C, Anisman H: Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiat 2003; 54:552-565.
34. Dadomo H, Sanghez V, Di Cristo L, Lori A, Ceresini G, Malinge I, Parmigiani S, Palanza P, Sheardown M, Bartolomucci A: Vulnerability to chronic subordination stress-induced depression-like disorders in adult 129SvEv male mice. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:1461-1471.
35. Cryan JF, Holmes A: The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005; 4:775-790.
36. Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A: Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 2002; 952:188-199.
37. Ducottet C, Griebel G, Belzung C: Effects of the selective nonpeptide corticotropin-releas-ing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:625-631.
38. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
39. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408.
40. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW: Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendo-crine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 2000; 97: 6079-6084.
41. Bowens N, Heydendael W, Bhatnagar S, Ja-cobson L: Lack of elevations in glucocorti-coids correlates with dysphoria-like behavior after repeated social defeat. Physiol Behav 2012; 105:958-965.
42. Yehuda R: Neuroendocrine aspects of PTSD. Handb Exp Pharmacol 2005; 169:371-403.
43. Antonijevic IA: Depressive disorders-is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006; 31:1-15.
44. Elzinga BM, Schmahl CG, Vermetten E, van Dyck R, Bremner JD: Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharma-cology 2003; 28:1656-1665.
45. Hauger RL, Millan MA, Lorang M, Harwood JP, Aguilera G: Corticotropin-releasing factor receptor and pituitary-adrenal responses during immobilization stress. Endocrinology 1988; 123:396-405.
46. Houshyar H, Galigniana MD, Pratt WB, Woods JH: Differential responsivity of the hy-pothalamic-pituitary-adrenal axis to gluco-corticoid negative-feedback and corticotro-pin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. J Neuroendocrinol 2001; 13:875-886.
47. Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD Jr: Serial CSF corticotro-pin-releasing hormone levels and adrenocor-tical activity in combat veterans with post-traumatic stress disorder. Am J Psychiatry 1999; 156:585-588.
48. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS: Elevated CSF corticotropin-re-leasing factor concentrations in posttraumat-ic stress disorder. Am J Psychiatry 1997; 154: 624-629.
49. Yehuda R, Southwick SM, Krystal JH, Brem-ner D, Charney DS, Mason JW: Enhanced suppression of cortisol following dexametha-sone administration in posttraumatic stress disorder. Am J Psychiatry 1993; 150:83-86.
50. Wood SK, Walker HE, Valentino RJ, Bhat-nagar S: Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corti-cotropin-releasing factor. Endocrinology 2010; 151:1795-1805.
51. Marti O, Harbuz MS, Andres R, Lightman SL, Armario A: Activation of the hypothalamic-pituitary axis in adrenalectomised rats: poten-tiation by chronic stress. Brain Res 1999; 821: 1-7.
52. Santibanez M, Gysling K, Forray MI: Desipra-mine prevents the sustained increase in corti-cotropin-releasing hormone-like immunore-activity induced by repeated immobilization stress in the rat central extended amygdala. J Neurosci Res 2006; 84:1270-1281.
53. Heim C, Ehlert U, Hellhammer DH: The potential role of hypocortisolism in the patho-physiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25:1-35.
54. Bonaz B, Rivest S: Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am J Physiol 1998; 275:1438-1449.
55. Swiergiel AH, Zhou Y, Dunn AJ: Effects of chronic footshock, restraint and corticotro-pin-releasing factor on freezing, ultrasonic vocalization and forced swim behavior in rats. Behav Brain Res 2007; 183:178-187.
56. Irwin M, Hauger R, Brown M: Central corti-cotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. Endocrinology 1992; 131:1047-1053.
57. Murphy EK, Sved AF, Finlay JM: Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in pre-frontal cortex of control or chronically stressed rats. Neuroscience 2003; 116:1081-1087.
58. Sabban EL: Catecholamine and stress; in Soreq H, Friedman A, Kaufer D (eds): Stress-From Molecules to Behavior: A Comprehensive Analysis of the Neurobiology of Stress Responses. Weinheim, Wiley, 2010, pp 19-35.
59. Cubells JF, Zabetian CP: Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 2004; 174:463-476.
60. Young EA, Breslau N: Cortisol and catechol-amines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 2004; 61:394-401.
61. Geracioti TD, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE, Kasckow JW: CSF norepinephrine concentrations in post-traumatic stress disorder. Am J Psychiatry 2001; 158:1227-1230.
62. Hawk LW, Dougall AL, Ursano RJ, Baum A: Urinary catecholamines and cortisol in recent-onset posttraumatic stress disorder after motor vehicle accidents. Psychosom Med 2000; 62:423-434.
63. Yehuda R, Southwick S, Giller EL, Ma X, Mason JW: Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 1992; 180: 321-325.
64. Mustapic M, Pivac N, Kozaric-Kovacic D, Dezeljin M, Cubells JF, Muck-Seler D: Dopa-mine beta-hydroxylase (DBH) activity and-1021C/T polymorphism of DBH gene in combat-related post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 144:1087-1089.
65. Rygula R, Abumaria N, Flügge G, Fuchs E, Rüther E, Havemann-Reinecke U: Anhedo-nia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res 2005; 162:127-134.
66. Erhardt A, Müller MB, Rodel A, Welt T, Ohl F, Holsboer F, Keck ME: Consequences of chronic social stress on behavior and vasopressin gene expression in the PVN of DBA/2OlaHsd mice-influence of treatment with the CRHR1-antagonist R121919/NBI 30775. J Psychophar-macol 2009; 23:31-39.
67. Post A, Ohl F, Almeida OF, Binder EB, Rück-er M, Welt S, Binder E, Holsboer F, Sillaber I: Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psycho-pharmacology (Berl) 2005; 180:150-158.
68. Vegas O, Garmendia L, Arregi A, Beitia G, Az-piroz A: Effects of antalarmin and nadolol on the relationship between social stress and pulmonary metastasis development in male OF1 mice. Behav Brain Res 2009; 205:200-206.
69. Zoumakis E, Rice KC, Gold PW, Chrousos GP: Potential uses of corticotropin-releasing hormone antagonists. Ann NY Acad Sci 2006; 1083:239-251.
70. Ayala AR, Pushkas J, Higley JD, Ronsaville D, Gold PW, Chrousos GP, Pacak K, Calis KA, Gerald M, Lindell S, Rice KC, Cizza G: Behavioral, adrenal, and sympathetic responses to long-term administration of an oral cortico-tropin-releasing hormone receptor antagonist in a primate stress paradigm. J Clin En-docrinol Metab 2004; 89:5729-5737.